T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancer Immunology Research Année : 2015

T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition

Résumé

Tumor immunotherapy has had demonstrable efficacy in patients with cancer. The most promising results have been with T-cell-based therapies. These include adoptive cell transfer of tumor-infiltrating lymphocytes, genetically engineered T cells, and immune checkpoint inhibitor antibodies. In this review, we describe the different T-cell-based strategies currently in clinical trials and put their applications, present and future, into perspective. Cancer Immunol Res; 3(10); 1115-22. ©2015 AACR
Fichier non déposé

Dates et versions

hal-01216199 , version 1 (15-10-2015)

Identifiants

Citer

Roch Houot, Liora Michal Schultz, Aurelien Marabelle, Holbrook Kohrt. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. Cancer Immunology Research, 2015, 3 (10), pp.1115--1122. ⟨10.1158/2326-6066.CIR-15-0190⟩. ⟨hal-01216199⟩
76 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More